HYDROXY PENTOXIFYLLINE
| Title | Journal |
|---|---|
| Macrolide antibiotics and survival in patients with acute lung injury. | Chest 20120501 |
| Macrolides for acute lung injury. | Chest 20120501 |
| Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats. | American journal of physiology. Endocrinology and metabolism 20110101 |
| Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. | Endocrinology 20100901 |
| 12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets. | The Journal of clinical endocrinology and metabolism 20100201 |
| Pharmacokinetic interaction between verapamil and methylxanthine derivatives in mice. | Drug metabolism letters 20100101 |
| Pharmacokinetic-pharmacodynamic modeling of methylxanthine derivatives in mice challenged with high-dose lipopolysaccharide. | Pharmacology 20100101 |
| Pentoxifylline as an adjunct therapy in children with cerebral malaria. | Malaria journal 20100101 |
| Pretreatment with R(+)-verapamil significantly reduces mortality and cytokine expression in murine model of septic shock. | International immunopharmacology 20090401 |
| Validation of a high-performance liquid chromatography method for pharmacokinetic evaluation of pentoxifylline and lisofylline in rat serum and tissues. | Acta poloniae pharmaceutica 20090101 |
| Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans. | European journal of pharmacology 20080310 |
| Enantioselective reduction of pentoxifylline to lisofylline using whole-cell Lactobacillus kefiri biotransformation. | Biotechnology journal 20070401 |
| Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice. | The Journal of pharmacy and pharmacology 20070401 |
| Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits. | Pharmacotherapy 20070201 |
| Enantioselective biotransformation of pentoxifylline into lisofylline using wine yeast biocatalysis. | Acta poloniae pharmaceutica 20070101 |
| Synthesis and biological evaluation of lisofylline (LSF) analogs as a potential treatment for Type 1 diabetes. | Bioorganic & medicinal chemistry letters 20060701 |
| Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes. | Biochemical and biophysical research communications 20060609 |
| Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. | European journal of pharmacology 20060327 |
| Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome. | American journal of physiology. Endocrinology and metabolism 20060101 |
| Use of liquid chromatography-tandem mass spectrometry for the analysis of pentoxifylline and lisofylline in plasma. | Biomedical chromatography : BMC 20050401 |
| Inflammatory blockade improves human pancreatic islet function and viability. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050301 |
| Lisofylline: a potential lead for the treatment of diabetes. | Biochemical pharmacology 20050101 |
| Pentoxifylline inhibits agonist-induced vasoconstriction in vascular smooth muscle and spontaneous peristalsis in isolated ileum. | Oncology research 20050101 |
| Inflammation blockade improves pancreatic islet function. | Transplantation proceedings 20041101 |
| Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal rats. | Metabolism: clinical and experimental 20040301 |
| The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation. | Transplantation 20040115 |
| Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition. | Endocrinology 20031201 |
| Emerging systemic pharmacologic approaches in acute respiratory distress syndrome. | Respiratory care clinics of North America 20031201 |
| Inhibition of STAT4 activation by lisofylline is associated with the protection of autoimmune diabetes. | Annals of the New York Academy of Sciences 20031101 |
| The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice. | Pancreas 20030501 |
| The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice. | Diabetologia 20020901 |
| Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. | Endocrinology 20020601 |
| Specific therapies for inhalation injury. | Critical care medicine 20020301 |
| Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model. | Critical care medicine 20020301 |
| Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. | Critical care medicine 20020101 |
| Lisofylline: anti-acute respiratory distress syndrome or just anti-inflammatory? | Critical care medicine 20020101 |
| Lisofylline and lysophospholipids ameliorate experimental colitis in rats. | Digestion 20020101 |
| Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. | Biochemical and biophysical research communications 20011116 |
| Immunotherapy of inflammatory demyelinating diseases of the central nervous system. | Immunologic research 20010101 |
| CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. | Shock (Augusta, Ga.) 19940401 |